Relating to access of records in controlled substance monitoring

HB 3177 expands access to West Virginia's Controlled Substances Monitoring Database to include medical school deans (and their designees) for monitoring faculty prescribing, employer-designated physician reviewers for tracking staff prescribing, and hospital chief medical officers (or designated physicians) for reviewing prescriber data at their facilities. These new access categories must comply with existing confidentiality rules, pharmacy board certification requirements, and patient privacy safeguards. The bill maintains the database's core purpose of monitoring prescribing patterns to improve patient safety, while ensuring all access requires proper authorization and follows state law. It does not change prescription rules or directly affect patients, but modifies who can review aggregated prescribing data for institutional oversight.